Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Severe acute hepatitis E infection presenting with acute abdomen and meningoencephalitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Intracranial entrapment of a haemodialysis catheter guidewire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hepatic epitheloid haemangioendothelioma: a rare malignant tumour

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term Consequences of Undiagnosed Celiac Seropositivity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Alexithymia and Inflammatory Bowel Disease: A Systematic Review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

A 76-year-old woman was treated with oral bisphosphonate, alendronate, for osteoporosis in an outpatient clinic. Routine blood tests 4 months after alendronate prescription surprisingly revealed severe hypophosphataemia. The patient was hospitalised and treated with intravenous and oral phosphate supplements. Alendronate was later reintroduced as treatment for osteoporosis and the patient once again presented with severe hypophosphataemia in subsequent routine blood tests. The patient had only presented with lower extremity pain, muscle weakness and difficulty walking. Blood tests in the emergency department both times reconfirmed severe hypophosphataemia. Plasma (p-)ionised calcium levels were normal or slightly elevated and p-parathyroid hormone levels were normal or slightly suppressed. The p-25-hydroxyvitamin-D and p-creatine were in the normal range. Critical illness, malabsorption, nutritional issues and genetics were reviewed as potential causes but considered unlikely. Phosphate levels were quickly restored each time on replacement therapy and the case was interpreted as bisphosphonate-induced severe hypophosphataemia.

OriginalsprogEngelsk
TidsskriftBMJ Case Reports
Vol/bind13
Udgave nummer10
ISSN1757-790X
DOI
StatusUdgivet - 8 okt. 2020

Bibliografisk note

© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 61114747